Latest News and Press Releases
Want to stay updated on the latest news?
-
Highlights: * Record fourth quarter revenue of EUR 7.0 million, up 44% year-over-year * Full year revenue of EUR 22.3 million, up 10% year-over-year * Approximately 3,400 Ablatherm-HIFU...
-
LYON, France, March 19, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it will showcase Ablatherm-HIFU and its next generation...
-
LYON, France, March 12, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in high-intensity focused ultrasound (HIFU) for the treatment of prostate cancer, announced today details...
-
LYON, France, March 10, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in high-intensity focused ultrasound (HIFU) for the treatment of prostate cancer, announced today that...
-
LYON, France, March 7, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Harlaching Hospital in Munich, Germany, long-term...
-
LYON, France, Feb. 22, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the patient awareness program to facilitate enrollment in...
-
LYON, France, Feb. 15, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Ablatherm(r)-HIFU was featured in presentations at three...
-
Journal of Endourology Highlights Ablatherm's Unique Sustainable Long-Term Clinical Data Ablatherm's Superior Safety and Efficacy Confirmed LYON, France, Feb....
-
LYON, France, Feb. 13, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in high-intensity focused ultrasound (HIFU) for the treatment of prostate cancer, announced today that Marc...
-
Record Fourth Quarter Revenue Financial Highlights: * Full year revenues of Euro 22.2 million, up 10% year-over-year * Record fourth quarter revenue of Euro 7.0 million, up...